Press Releases
 
Cytomegalovirus Infection Therapeutics Pipeline Analysis 2017

United States, 12 August 2017 -- The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline.

The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations. The pipeline is being driven by different factors such as increasing awareness regarding the cytomegalovirus infection treatment, high demand for safe and effective medications, technological advancements and increasing prevalence of the cytomegalovirus.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-infection-therapeutics-pipeline-analysis

According to Centers for Disease Control and Prevention, cytomegalovirus, is a common virus that infects people of all ages. Over half of ###### by age 40 have been infected with cytomegalovirus. Once cytomegalovirus is in a person's body, it stays there for life and can reactivate., with a major number of people infected with cytomegalovirus showing no signs or symptoms of the disease. However, cytomegalovirus infection can cause serious health problems for people with weakened immune systems, as well as babies infected with the virus before they are born. When a baby is born with cytomegalovirus infection, it is called congenital cytomegalovirus infection. About one out of every 150 babies are born with congenital cytomegalovirus infection. However, only about one in five babies with congenital cytomegalovirus infection will be sick from the virus or will have long-term health problems. In some cases, infection in healthy people can cause mild illness that may include fever, sore throat, fatigue and swollen glands.

Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/cytomegalovirus-infection-therapeutics-pipeline-analysis/toc-sample

Some of the companies having a pipeline of cytomegalovirus infection therapeutics include Biotest AG, Merck & Co., Inc., Chimerix Inc., Astellas Pharma, Inc., CSL Behring, Cell Medica Ltd., GlaxoSmithKline plc, Pfizer, Inc., F. Hoffmann-La Roche and AstraZeneca plc.

# # #


Submitted by Jacob, P&S Market Research on Saturday, 12 August 2017 at 5:29 AM
Category: Health Care & Medical
 
Related News

Prescription Doctor - Portal operator allowing access to regulated UK online doctor and pharmacy ser
Tuesday, 23 Jan 2018

Idiopathic Short Stature Market Latest Trends and Forecast Analysis Upto 2020
Tuesday, 23 Jan 2018

Healthcare Facilities Management Market to Become Worth US$577.92 bn by 2025
Tuesday, 23 Jan 2018

Multiple Reaction Monitoring Assay Market to Develop Rapidly by 2024
Tuesday, 23 Jan 2018

High Throughput Process Development Market to Become Worth US$ 18.3 bn by 2022
Tuesday, 23 Jan 2018

Related Events

Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
Monday, 22 Jan 2018

Cell & Gene Therapy World
Monday, 22 Jan 2018

Immuno-Oncology Frontiers World
Monday, 22 Jan 2018

Patients as Partners Europe
Tuesday, 23 Jan 2018

Hyphenated Techniques in Chromatography Cardiff January 2018
Wednesday, 24 Jan 2018

Latest News

Things to consider prior to buy injection molds
Tuesday, 23 Jan 2018

Alkylated Naphthalene Sulfonate Market Overview | Forecast & Analysis (2016-2020)
Tuesday, 23 Jan 2018

Global Baby Care Product Market - By End User, Vendors and Geography Market Shares, Forecasts and Tr
Tuesday, 23 Jan 2018

ExpressVPN Update Supports Android TV and Amazon Fire TV
Tuesday, 23 Jan 2018

Make Passive AdSense Earnings via Android Apps from AdSense Gorilla
Tuesday, 23 Jan 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 January 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
  • Advancing Construction Claims 2018 Conference Atlanta, GA
  • Cell & Gene Therapy World
  • Immuno-Oncology Frontiers World
  • Patients as Partners Europe

  • Latest Jobs
    Sorry, there are currently no entries posted here.